Laureus Capital

Impossible Cloud is a pioneering decentralized cloud platform that harnesses web3 technology to deliver enterprise-grade multi-service cloud solutions. By offering faster, more affordable, and secure alternatives to traditional hyperscalers and private clouds, it focuses on providing businesses with a comprehensive suite of services tailored to meet their needs. The platform facilitates unlimited storage capacity and ensures 100% durability and availability, all without hidden costs or the necessity for cryptocurrency transactions. Its fiat-based payment system caters specifically to B2B customers, streamlining the financial aspect of cloud services. Furthermore, Impossible Cloud connects users to a global network of enterprise-grade storage hubs, which enhances performance and efficiency by reducing latency and optimizing data access near the customer's location.

Impossible Cloud is a pioneering decentralized cloud platform that harnesses web3 technology to deliver enterprise-grade multi-service cloud solutions. By offering faster, more affordable, and secure alternatives to traditional hyperscalers and private clouds, it focuses on providing businesses with a comprehensive suite of services tailored to meet their needs. The platform facilitates unlimited storage capacity and ensures 100% durability and availability, all without hidden costs or the necessity for cryptocurrency transactions. Its fiat-based payment system caters specifically to B2B customers, streamlining the financial aspect of cloud services. Furthermore, Impossible Cloud connects users to a global network of enterprise-grade storage hubs, which enhances performance and efficiency by reducing latency and optimizing data access near the customer's location.

Ethris GmbH is a biotechnology company based in Planegg, Germany, specializing in the development of innovative therapeutic solutions for diseases with unmet medical needs. The company has a focus on transcript therapeutics, particularly through its SNIM RNA platform, which offers a novel approach to treating various conditions by enabling the production of therapeutic proteins within the patient’s body. This platform presents an alternative to traditional recombinant protein and gene therapies, addressing a range of diseases, including rare and genetically predetermined conditions. Ethris also develops Magnetovax, a personalized tumor vaccine platform that utilizes magnetic fields for localized activation in tumors. The company has established strategic research collaborations with major pharmaceutical firms, enhancing its capabilities in regenerative medicine and therapeutic development. Founded in 2009, Ethris continues to advance its technologies to meet diverse medical needs.

Impossible Cloud is a pioneering decentralized cloud platform that harnesses web3 technology to deliver enterprise-grade multi-service cloud solutions. By offering faster, more affordable, and secure alternatives to traditional hyperscalers and private clouds, it focuses on providing businesses with a comprehensive suite of services tailored to meet their needs. The platform facilitates unlimited storage capacity and ensures 100% durability and availability, all without hidden costs or the necessity for cryptocurrency transactions. Its fiat-based payment system caters specifically to B2B customers, streamlining the financial aspect of cloud services. Furthermore, Impossible Cloud connects users to a global network of enterprise-grade storage hubs, which enhances performance and efficiency by reducing latency and optimizing data access near the customer's location.